News
Dr. Vinay Prasad, a controversial figure and critic of the FDA, resigned from his high-ranking position at the agency after ...
U.S. stocks end lower, with the S&P 500 and Nasdaq pausing its run to records as the Fed meets on rates and ahead of Mag 7 earnings.
Starbucks shares are up nearly 5% after releasing results and announcing a 'wave of innovation' next year. SoFi Technologies shares, which rose 6.6% on Tuesday following well-received earnings, are ...
Dr. Vinay Prasad, the controversial critic of the US Food and Drug Administration who took a top role at the regulatory ...
Who is Vinay Prasad? US FDA's top regulator exits agency after controversy over Sarepta gene therapy
Dr. Vinay Prasad has resigned from the FDA after less than three months amid controversy over Sarepta Therapeutics' gene ...
Dr Vinay Prasad resigned as the top vaccine and gene therapy official of the US Food and Drug Administration (FDA) on Tuesday (July 29) in the wake of a vilification campaign led by right-wing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results